Latest Head and neck cancer Stories
Transplant patients who develop head and neck cancer are more likely to be non-smokers and non-drinkers, and less likely than their non-transplant counterparts to survive past one year of diagnosis.
Nearly 12,000 people will die of head and neck cancer in the United States this year and worldwide cases will exceed half a million.
According to a new study, oral infections with the human papillomavirus (HPV) are more common in men than women.
Research physicians from Georgetown Lombardi Comprehensive Cancer Center will present new data about a complex group of cancers known as head and neck cancers at the Multidisciplinary Head and Neck Cancer Symposium, January 26 through 28, in Phoenix, Arizona.
Patients with head and neck cancers who have been treated with newer, more sophisticated radiation therapy technology enjoy a better quality of life than those treated with older radiation therapy equipment.
Routine use of positron emission tomography/computed tomography (PET/CT) scans in head and neck cancer patient follow-up can detect local recurrences before they become clinically apparent and may improve the outcome of subsequent salvage therapy.
Head and neck cancers respond well to the anti-cancer drug erlotinib when it is administered before surgery and a stronger dose is given to patients who smoke.
Radiation therapy with or without chemotherapy is less effective for patients with HIV when compared to the recurrence and overall survival rates in patients who do not have HIV.
In Denmark, implementing a national fast track system for cancer patients reduced the waiting time between a patient's initial meeting with a health care provider and their first treatment by four weeks when comparing 2010 to 2002.
Oral HPV infection is more common among men than women, explaining why men are more prone than women to develop an HPV related head and neck cancer.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.